Lv4
446 积分 2025-02-09 加入
A research protocol for a prospective, multicenter, cohort study on interferon therapy for chronic hepatitis B combined with metabolism-associated fatty liver disease to achieve clinical cure
7小时前
待确认
Metabolic associated fatty liver disease induced hepatocyte apoptosis to eliminate hepatitis B virus
8小时前
已完结
Hepatic Steatosis Inhibits Hepatitis B Virus Replication by Promoting miR‐122‐5p‐SOX4
8小时前
已完结
T follicular helper cells improve the response of patients with chronic hepatitis B to interferon by promoting HBsAb production
7天前
已完结
The potential effect of HBV vaccination on off-treatment HBsAg reversion after interferon-induced HBsAg clearance
7天前
已完结
CTLA4 modulates B cell receptor signals to inhibit HBsAb secretion in chronic hepatitis B patients
7天前
已完结
Group-based trajectory modeling for declines in hepatitis B surface antigen over time accurately identifies chronic hepatitis B patients achieving functional cure: a single-center cohort study in China
17天前
已完结
A randomized, double-blind, phase 3, non-inferiority trial of pradefovir mesylate versus tenofovir disoproxil fumarate in Chinese patients with chronic hepatitis B
17天前
已完结
Distinct virologic trajectories in chronic hepatitis B identify heterogeneity in response to nucleos(t)ide analogue therapy
1个月前
已完结
Switching from entecavir to tenofovir alafenamide for chronic hepatitis B patients with low-level viraemia
1个月前
已完结
皖公网安备34019202002308
